CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes Science 25. Mai 2023 ShareTwitterFacebookXingLinkedin Read Article
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies. Science 25. Mai 2023 ShareTwitterFacebookXingLinkedin Read Article
(Bersacapavir) In Participants With Moderate Hepatic Impairment. Science 25. Mai 2023 ShareTwitterFacebookXingLinkedin Read Article
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure. Science 25. Mai 2023 ShareTwitterFacebookXingLinkedin Read Article
Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Midazolam microdosing applied in early clinical development for drug-drug interaction assessment. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton’s tyrosine kinase, in Phase I clinical trials in healthy volunteers. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Diabetic Macular Edema in Diabetological Practices. Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
